{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T14:06:31Z","timestamp":1789826791483,"version":"4.0.1"},"reference-count":78,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2023,3,7]],"date-time":"2023-03-07T00:00:00Z","timestamp":1678147200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Progetto POR FESR LAZIO-2014-2020","award":["A0375-2020-36535"],"award-info":[{"award-number":["A0375-2020-36535"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Viral respiratory tract infections (RTIs) are responsible for significant morbidity and mortality worldwide. A prominent feature of severe respiratory infections, such as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, is the cytokine release syndrome. Therefore, there is an urgent need to develop different approaches both against viral replication and against the consequent inflammation. N-acetylglucosamine (GlcNAc), a glucosamine (GlcN) derivative, has been developed as an immunomodulatory and anti-inflammatory inexpensive and non-toxic drug for non-communicable disease treatment and\/or prevention. Recent studies have suggested that GlcN, due to its anti-inflammatory activity, could be potentially useful for the control of respiratory virus infections. Our present study aimed to evaluate in two different immortalized cell lines whether GlcNAc could inhibit or reduce both viral infectivity and the inflammatory response to viral infection. Two different viruses, frequent cause of upper and lower respiratory tract infections, were used: the H1N1 Influenza A virus (IAV) (as model of enveloped RNA virus) and the Human adenovirus type 2 (Adv) (as model of naked DNA virus). Two forms of GlcNAc have been considered, bulk GlcNAc and GlcNAc in nanoform to overcome the possible pharmacokinetic limitations of GlcNAc. Our study suggests that GlcNAc restricts IAV replication but not Adv infection, whereas nano-GlcNAc inhibits both viruses. Moreover, GlcNAc and mainly its nanoformulation were able to reduce the pro-inflammatory cytokine secretion stimulated by viral infection. The correlation between inflammatory and infection inhibition is discussed.<\/jats:p>","DOI":"10.3390\/ijms24065129","type":"journal-article","created":{"date-parts":[[2023,3,8]],"date-time":"2023-03-08T02:30:23Z","timestamp":1678242623000},"page":"5129","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["In Vitro Antiviral and Anti-Inflammatory Activities of N-Acetylglucosamine: Development of an Alternative and Safe Approach to Fight Viral Respiratory Infections"],"prefix":"10.3390","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3871-4976","authenticated-orcid":false,"given":"Magda","family":"Marchetti","sequence":"first","affiliation":[{"name":"National Centre for Innovative Technologies in Public Health, National Institute of Health, Viale Regina Elena 299, 00161 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7857-9620","authenticated-orcid":false,"given":"Barbara","family":"De Berardis","sequence":"additional","affiliation":[{"name":"National Centre for Innovative Technologies in Public Health, National Institute of Health, Viale Regina Elena 299, 00161 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1093-7764","authenticated-orcid":false,"given":"Irene","family":"Bigioni","sequence":"additional","affiliation":[{"name":"Department of Biochemical Sciences, Sapienza University of Rome, 00185 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9569-8952","authenticated-orcid":false,"given":"Alessia","family":"Mariano","sequence":"additional","affiliation":[{"name":"Department of Biochemical Sciences, Sapienza University of Rome, 00185 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4909-7598","authenticated-orcid":false,"given":"Fabiana","family":"Superti","sequence":"additional","affiliation":[{"name":"National Centre for Innovative Technologies in Public Health, National Institute of Health, Viale Regina Elena 299, 00161 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3323-6015","authenticated-orcid":false,"given":"Anna","family":"Scotto d\u2019Abusco","sequence":"additional","affiliation":[{"name":"Department of Biochemical Sciences, Sapienza University of Rome, 00185 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,3,7]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.rcl.2005.10.009","article-title":"Acute Lung Infections in Normal and Immunocompromised Hosts","volume":"44","author":"Waite","year":"2006","journal-title":"Radiol. Clin. North Am."},{"key":"ref_2","unstructured":"Pattemore, P.K., and Jennings, L.C. (2008). Pediatric Respiratory Medicine, Elsevier."},{"key":"ref_3","unstructured":"Asher, M.I., and Grant, C.C. (2008). Pediatric Respiratory Medicine, Elsevier."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.ejim.2004.01.006","article-title":"The common cold: A review of the literature","volume":"15","author":"Wat","year":"2004","journal-title":"Eur. J. Intern. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1016\/S0140-6736(10)61459-6","article-title":"Viral pneumonia","volume":"377","author":"Ruuskanen","year":"2011","journal-title":"Lancet"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1097\/MCP.0b013e3282f4a99f","article-title":"Viral infections in patients with chronic obstructive pulmonary disease","volume":"14","author":"Varkey","year":"2008","journal-title":"Curr. Opin. Pulm. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s11908-010-0084-5","article-title":"The Role of Adenovirus in Respiratory Tract Infections","volume":"12","author":"Kunz","year":"2010","journal-title":"Curr. Infect. Dis. Rep."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1086\/320146","article-title":"Lower Respiratory Tract Infections due to Adenovirus in Hospitalized Korean Children: Epidemiology, Clinical Features, and Prognosis","volume":"32","author":"Hong","year":"2001","journal-title":"Clin. Infect. Dis."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.coviro.2018.12.004","article-title":"Emergence and re-emergence of respiratory adenoviruses in the United States","volume":"34","author":"Kajon","year":"2019","journal-title":"Curr. Opin. Virol."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Kleinehr, J., Wilden, J.J., Boergeling, Y., Ludwig, S., and Hrincius, E.R. (2021). Metabolic modifications by common respiratory viruses and their potential as new antiviral targets. Viruses, 13.","DOI":"10.3390\/v13102068"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1177\/0885066620960687","article-title":"Comparative Study on the Effect of Cidofovir Treatment for Severe Adenovirus Pneumonia","volume":"36","author":"Moon","year":"2021","journal-title":"J. Intensive Care Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1038\/sj.bmt.1702820","article-title":"Early diagnosis of adenovirus infection and treatment with cidofovir after bone marrow transplantation in children","volume":"27","author":"Legrand","year":"2001","journal-title":"Bone Marrow Transplant."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1186\/s13054-019-2539-x","article-title":"Influenza virus-related critical illness: Pathophysiology and epidemiology","volume":"23","author":"Kalil","year":"2019","journal-title":"Crit. Care"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1186\/s13054-019-2491-9","article-title":"Influenza virus-related critical illness: Prevention, diagnosis, treatment","volume":"23","author":"Chow","year":"2019","journal-title":"Crit. Care"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/1824-7288-40-65","article-title":"Inter-society consensus document on treatment and prevention of bronchiolitis in newborns and infants","volume":"40","author":"Baraldi","year":"2014","journal-title":"Ital. J. Pediatr."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1183\/09031936.00084114","article-title":"Early-life origins of chronic respiratory diseases: Understanding and promoting healthy ageing","volume":"44","author":"Carraro","year":"2014","journal-title":"Eur. Respir. J."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1177\/1753465813479428","article-title":"Early life influences on the development of chronic obstructive pulmonary disease","volume":"7","author":"Stocks","year":"2013","journal-title":"Ther. Adv. Respir. Dis."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1093\/cid\/ciaa213","article-title":"A Glimpse Into the Origins of Genetic Diversity in the Severe Acute Respiratory Syndrome Coronavirus 2","volume":"71","author":"Wertheim","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1164\/ajrccm\/151.5_Pt_1.1659","article-title":"Mechanisms of airway narrowing and hyperresponsiveness in viral respiratory tract infections","volume":"151","author":"Hegele","year":"1995","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.immuni.2020.05.004","article-title":"Respiratory Virus Infections: Understanding COVID-19","volume":"52","author":"Subbarao","year":"2020","journal-title":"Immunity"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s00441-010-1043-z","article-title":"Respiratory epithelial cells in innate immunity to influenza virus infection","volume":"343","author":"Sanders","year":"2011","journal-title":"Cell Tissue Res."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1086\/499955","article-title":"Viral Pneumonia in Older Adults","volume":"42","author":"Falsey","year":"2006","journal-title":"Clin. Infect. Dis."},{"key":"ref_23","first-page":"010401","article-title":"Epidemiology and etiology of childhood pneumonia in 2010: Estimates of incidence, severe morbidity, mortality, underlying risk factors and causative pathogens for 192 countries","volume":"3","author":"Rudan","year":"2013","journal-title":"J. Glob. Health"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"110982","DOI":"10.1016\/j.biopha.2020.110982","article-title":"Early use of non-steroidal anti-inflammatory drugs in COVID-19 might reverse pathogenesis, prevent complications and improve clinical outcomes","volume":"133","author":"Kelleni","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/S1473-3099(20)30132-8","article-title":"COVID-19: Combining antiviral and anti-inflammatory treatments","volume":"20","author":"Stebbing","year":"2020","journal-title":"Lancet Infect. Dis."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1099\/0022-1317-14-3-251","article-title":"Inhibition of the Multiplication of Enveloped RNA-viruses by Glucosamine and 2-Deoxy-D-Glucose","volume":"14","author":"Kaluza","year":"1972","journal-title":"J. Gen. Virol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0042-6822(75)90384-0","article-title":"Two different mechanisms of the inhibition of the multiplication of enveloped viruses by glucosamine","volume":"63","author":"Scholtissek","year":"1975","journal-title":"Virology"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1111\/j.2042-7158.1988.tb05283.x","article-title":"Vanden Inhibition of the Multiplication of Enveloped and Non-enveloped Viruses by Glucosamine","volume":"40","author":"Delgadillo","year":"2011","journal-title":"J. Pharm. Pharmacol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1093\/glycob\/cwaa083","article-title":"The case for re-examining glycosylation inhibitors, mimetics, primers and glycosylation decoys as antivirals and anti-inflammatories in COVID19","volume":"30","author":"Laine","year":"2020","journal-title":"Glycobiology"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"102574","DOI":"10.1016\/j.amsu.2021.102574","article-title":"An observational cohort study to assess N-acetylglucosamine for COVID-19 treatment in the inpatient setting","volume":"68","author":"Hassan","year":"2021","journal-title":"Ann. Med. Surg."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.6064\/2012\/489208","article-title":"N-Acetylglucosamine Functions in Cell Signaling","volume":"2012","author":"Konopka","year":"2012","journal-title":"Scientifica"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1007\/s10753-012-9459-0","article-title":"Suppressive Effects of N-Acetyl-d-Glucosamine on Rheumatoid Arthritis Mouse Models","volume":"35","author":"Azuma","year":"2012","journal-title":"Inflammation"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/cei.12313","article-title":"Collagen-induced arthritis: Severity and immune response attenuation using multivalent N-acetyl glucosamine","volume":"177","author":"Richter","year":"2014","journal-title":"Clin. Exp. Immunol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1016\/S0149-2918(96)80073-7","article-title":"Pilot study of oral polymeric N-acetyl-d-glucosamine as a potential treatment for patients with osteoarthritis","volume":"18","author":"Talent","year":"1996","journal-title":"Clin. Ther."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0140-6736(00)03610-2","article-title":"Long-term effects of glucosamine sulphate on osteoarthritis progression: A randomised, placebo-controlled clinical trial","volume":"357","author":"Reginster","year":"2001","journal-title":"Lancet"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0144-8617(03)00170-X","article-title":"Enhanced healing of cartilaginous injuries by N-acetyl-d-glucosamine and glucuronic acid","volume":"54","author":"Tamai","year":"2003","journal-title":"Carbohydr. Polym."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.3390\/md8092493","article-title":"N-Acetylglucosamine: Production and Applications","volume":"8","author":"Chen","year":"2010","journal-title":"Mar. Drugs"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1046\/j.1365-2036.2000.00883.x","article-title":"A pilot study of N-acetyl glucosamine, a nutritional substrate for glycosaminoglycan synthesis, in paediatric chronic inflammatory bowel disease","volume":"14","author":"Salvatore","year":"2000","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"40133","DOI":"10.1074\/jbc.M111.277814","article-title":"N-acetylglucosamine inhibits T-helper 1 (Th1)\/T-helper 17 (Th17) cell responses and treats experimental autoimmune encephalomyelitis","volume":"286","author":"Grigorian","year":"2011","journal-title":"J. Biol. Chem."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"17413","DOI":"10.1074\/jbc.RA120.015595","article-title":"N-acetylglucosamine drives myelination by triggering oligodendrocyte precursor cell differentiation","volume":"295","author":"Sy","year":"2020","journal-title":"J. Biol. Chem."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Lee, S.-U., Li, C.F., Mortales, C.-L., Pawling, J., Dennis, J.W., Grigorian, A., and Demetriou, M. (2019). Increasing cell permeability of N-acetylglucosamine via 6-acetylation enhances capacity to suppress T-helper 1 (TH1)\/TH17 responses and autoimmunity. PLoS ONE, 14.","DOI":"10.1371\/journal.pone.0214253"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/j.joca.2005.07.009","article-title":"Glucosamine oral bioavailability and plasma pharmacokinetics after increasing doses of crystalline glucosamine sulfate in man","volume":"13","author":"Persiani","year":"2005","journal-title":"Osteoarthr. Cartil."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.joca.2007.01.019","article-title":"Synovial and plasma glucosamine concentrations in osteoarthritic patients following oral crystalline glucosamine sulphate at therapeutic dose","volume":"15","author":"Persiani","year":"2007","journal-title":"Osteoarthr. Cartil."},{"key":"ref_44","first-page":"847","article-title":"Glucosamine and its N-acetyl-phenylalanine derivative prevent TNF-\u03b1-induced transcriptional activation in human chondrocytes","volume":"25","author":"Cicione","year":"2007","journal-title":"Clin. Exp. Rheumatol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"R18","DOI":"10.1186\/ar2920","article-title":"A peptidyl-glucosamine derivative affects IKK\u03b1 kinase activity in human chondrocytes","volume":"12","author":"Politi","year":"2010","journal-title":"Arthritis Res. Ther."},{"key":"ref_46","unstructured":"EC (2022). Commission recommendation 2022\/3689 of 10 June 2022 on the definition of nanomaterial. Off. J. Eur. Union, C229, 1\u20135."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1515\/hsz-2018-0304","article-title":"The role of the innate immune system on pulmonary infections","volume":"400","author":"McLaughlin","year":"2019","journal-title":"Biol. Chem."},{"key":"ref_48","first-page":"010408","article-title":"Aetiological role of common respiratory viruses in acute lower respiratory infections in children under five years: A systematic review and meta\u2013analysis","volume":"5","author":"Shi","year":"2015","journal-title":"J. Glob. Health"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1002\/jmv.25333","article-title":"Epidemiology of human adenovirus infection in children hospitalized with lower respiratory tract infections in Hunan, China","volume":"91","author":"Xie","year":"2019","journal-title":"J. Med. Virol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"S563","DOI":"10.1093\/infdis\/jiy662","article-title":"The Etiological Role of Common Respiratory Viruses in Acute Respiratory Infections in Older Adults: A Systematic Review and Meta-analysis","volume":"222","author":"Shi","year":"2020","journal-title":"J. Infect. Dis."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1097\/00006454-199512000-00005","article-title":"Viral etiology and epidemiology of acute lower respiratory tract infections in Korean children","volume":"14","author":"Yun","year":"1995","journal-title":"Pediatr. Infect. Dis. J."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s00011-016-0996-0","article-title":"The inflammatory response triggered by Influenza virus: A two edged sword","volume":"66","author":"Tavares","year":"2017","journal-title":"Inflamm. Res."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"104879","DOI":"10.1016\/j.antiviral.2020.104879","article-title":"A synthetic stigmastane displays antiadenoviral activity and reduces the inflammatory response to viral infection","volume":"183","author":"Michelini","year":"2020","journal-title":"Antiviral Res."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1056\/NEJMcibr0805865","article-title":"Insights into Inflammation and Influenza","volume":"359","author":"Simmons","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1128\/MMBR.05015-11","article-title":"Into the Eye of the Cytokine Storm","volume":"76","author":"Tisoncik","year":"2012","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1002\/jmv.1045","article-title":"Symptom pathogenesis during acute influenza: Interleukin-6 and other cytokine responses","volume":"64","author":"Kaiser","year":"2001","journal-title":"J. Med. Virol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.resp.2014.07.010","article-title":"Magnitude of influenza virus replication and cell damage is associated with interleukin-6 production in primary cultures of human tracheal epithelium","volume":"202","author":"Yamaya","year":"2014","journal-title":"Respir. Physiol. Neurobiol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1172\/JCI1355","article-title":"Local and systemic cytokine responses during experimental human influenza A virus infection. Relation to symptom formation and host defense","volume":"101","author":"Hayden","year":"1998","journal-title":"J. Clin. Investig."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0929-6646(09)60102-9","article-title":"Influenza Pandemics: Past, Present and Future","volume":"105","author":"Hsieh","year":"2006","journal-title":"J. Formos. Med. Assoc."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"R301","DOI":"10.1186\/cc13171","article-title":"Inhibition of the inflammatory cytokine tumor necrosis factor-alpha with etanercept provides protection against lethal H1N1 influenza infection in mice","volume":"17","author":"Shi","year":"2013","journal-title":"Crit. Care"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"6450","DOI":"10.1128\/JVI.75.14.6450-6459.2001","article-title":"Adenovirus Type 7 Induces Interleukin-8 Production via Activation of Extracellular Regulated Kinase 1\/2","volume":"75","author":"Alcorn","year":"2001","journal-title":"J. Virol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1128\/CMR.5.3.262","article-title":"Adenoviruses in the immunocompromised host","volume":"5","author":"Hierholzer","year":"1992","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"551413","DOI":"10.3389\/fimmu.2020.551413","article-title":"Adenovirus 7 Induces Interlukin-6 Expression in Human Airway Epithelial Cells via p38\/NF-\u03baB Signaling Pathway","volume":"11","author":"Qi","year":"2020","journal-title":"Front. Immunol."},{"key":"ref_64","first-page":"1349","article-title":"Fatal adenovirus pneumonia in a newborn identified by electron microscopy and in situ hybridization","volume":"113","author":"Abbondanzo","year":"1989","journal-title":"Arch. Pathol. Lab. Med."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1097\/INF.0b013e31819075a6","article-title":"Clinical Features, Adenovirus Types, and Local Production of Inflammatory Mediators in Adenovirus Infections","volume":"28","author":"Moro","year":"2009","journal-title":"Pediatr. Infect. Dis. J."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"6200","DOI":"10.1073\/pnas.0308368101","article-title":"Adenovirus-induced maturation of dendritic cells through a PI3 kinase-mediated TNF-\u03b1 induction pathway","volume":"101","author":"Philpott","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1002\/(SICI)1521-2254(200005\/06)2:3<194::AID-JGM102>3.0.CO;2-5","article-title":"The role of IL-6 in the inflammatory and humoral response to adenoviral vectors","volume":"2","author":"Benihoud","year":"2000","journal-title":"J. Gene Med."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/nm0395-182b","article-title":"IL-6 release and airway administration of human CFTR cDNA adenovirus vector","volume":"1","author":"McElvaney","year":"1995","journal-title":"Nat. Med."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/ng0994-42","article-title":"Administration of an adenovirus containing the human CFTR cDNA to the respiratory tract of individuals with cystic fibrosis","volume":"8","author":"Crystal","year":"1994","journal-title":"Nat. Genet."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0065-2776(08)60509-X","article-title":"lnterleukin-8 and Related Chemotactic Cytokines\u2014CXC and CC Chemokines","volume":"55","author":"Baggiolini","year":"1993","journal-title":"Adv. Immunol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1159\/000237218","article-title":"lnterleukin-8 in Airway Inflammation in Patients with Asthma and Chronic Obstructive Pulmonary Disease","volume":"109","author":"Nocker","year":"1996","journal-title":"Int. Arch. Allergy Immunol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1165\/ajrcmb.21.4.3677","article-title":"Type-Specific Induction of Interleukin-8 by Adenovirus","volume":"21","author":"Metcalf","year":"1999","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Superti, F. (2020). Lactoferrin from Bovine Milk: A Protective Companion for Life. Nutrients, 12.","DOI":"10.3390\/nu12092562"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s12985-022-01823-0","article-title":"In vitro anti-influenza assessment of anionic compounds ascorbate, acetate and citrate","volume":"19","author":"Mehrbod","year":"2022","journal-title":"Virol. J."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.nbt.2009.03.007","article-title":"Recent advancements for the evaluation of anti-viral activities of natural products","volume":"25","author":"Chattopadhyay","year":"2009","journal-title":"N. Biotechnol."},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Mehrbod, P., Abdalla, M.A., Njoya, E.M., Ahmed, A.S., Fotouhi, F., Farahmand, B., Gado, D.A., Tabatabaian, M., Fasanmi, O.G., and Eloff, J.N. (2018). South African medicinal plant extracts active against influenza A virus. BMC Complement. Altern. Med., 18.","DOI":"10.1186\/s12906-018-2184-y"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.3109\/17435390.2012.741724","article-title":"Comparative study of ZnO and TiO 2 nanoparticles: Physicochemical characterisation and toxicological effects on human colon carcinoma cells","volume":"7","author":"Barone","year":"2013","journal-title":"Nanotoxicology"},{"key":"ref_78","first-page":"1667","article-title":"Inactivation of influenza virus by a blend of essential plant oil vapour and aerosol","volume":"35","author":"Superti","year":"2021","journal-title":"J. Biol. Regul. Homeost. Agents"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/6\/5129\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T18:50:10Z","timestamp":1760122210000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/6\/5129"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,7]]},"references-count":78,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2023,3]]}},"alternative-id":["ijms24065129"],"URL":"https:\/\/doi.org\/10.3390\/ijms24065129","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,7]]}}}